Humacyte logo

Humacyte share price today

(HUMA)

Humacyte share price is $5.5 & ₹470.46 as on 30 Dec 2024, 20.30 hrs IST

$5.5

0.21

(3.97%)

Market is closed - opens 8 PM, 30 Dec 2024

View live Humacyte share price in Dollar and Rupees. Guide to invest in Humacyte from India. Also see the sentimental analysis on Indian investors investing in Humacyte. Get details on the Indian mutual funds that are investing in Humacyte. Get Analyst recommendations and forecasts along with all the Humacyte's financials.

Humacyte share price movements

  • Today's Low: $5.14
    Today's High: $5.64

    Day's Volatility :8.87%

  • 52 Weeks Low: $2.48
    52 Weeks High: $9.97

    52 Weeks Volatility :75.13%

Humacyte Returns

PeriodHumacyte IncSector (Health Care)Index (Russel 2000)
3 Months
1.1%
-9.8%
0.0%
6 Months
2.42%
-4.7%
0.0%
1 Year
90.31%
1.9%
0.0%
3 Years
52.78%
-1.8%
-21.3%

Humacyte Key Statistics

in dollars & INR

Previous Close
$5.5
Open
$5.38
Today's High
$5.64
Today's Low
$5.14
Market Capitalization
$680.7M
Today's Volume
$9.1M
52 Week High
$9.97
52 Week Low
$2.48
Revenue TTM
$0.0
EBITDA
$-105.3M
Earnings Per Share (EPS)
$-1.34
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-850.81%

How to invest in Humacyte from India?

It is very easy for Indian residents to invest directly in Humacyte from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Humacyte stock in both Indian Rupees (INR) and US Dollars (USD). Search for Humacyte or HUMA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Humacyte or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Humacyte shares which would translate to 0.156 fractional shares of Humacyte as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Humacyte, in just a few clicks!

Returns in Humacyte for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Humacyte investment value today

Current value as on today

₹1,93,106

Returns

₹93,106

(+93.11%)

Returns from Humacyte Stock

₹90,311 (+90.31%)

Dollar Returns

₹2,795 (+2.79%)

Indian investors sentiment towards Humacyte

285.71%

Period: Sep 30, 2024 to Dec 29, 2025. Change in 30 Days versus previous period

Investment in Humacyte from India has grown in the last 30 days as on Dec 30, 2025. 285.71% more purchase transactions for Humacyte in the last 30 days versus the previous period.

264%

Period: Sep 30, 2024 to Dec 29, 2025. Change in 30 Days versus previous period

Search volume for Humacyte on INDmoney from India has grown in the last 30 days as on Dec 30, 2025. 264% more investors are searching Humacyte in the last 30 days versus the previous period.

Global Institutional Holdings in Humacyte

  • BlackRock Inc

    5.55%

  • Vanguard Group Inc

    3.93%

  • State Street Corp

    3.70%

  • Geode Capital Management, LLC

    1.59%

  • Millennium Management LLC

    0.99%

  • VOLORIDGE INVESTMENT MANAGEMENT, LLC

    0.98%

Analyst Recommendation on Humacyte

Buy

    83%Buy

    16%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Humacyte(by analysts ranked 0 to 5 stars)

Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
11
11
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Humacyte

What analysts predicted

Upside of 149.35%

Current:

$5.50

Target:

$13.71

Insights on Humacyte

  • Price Movement

    In the last 7 days, HUMA stock has moved up by 18.3%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 31.0K → 10.79M (in $), with an average increase of 99.7% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -56.66M → -39.20M (in $), with an average increase of 44.5% per quarter

Humacyte Technicals Summary

Sell

Neutral

Buy

Humacyte is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Humacyte Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Humacyte Inc
23.6%
2.42%
90.31%
52.78%
52.78%
Regeneron Pharmaceuticals, Inc.
-6.55%
-32.6%
-21.28%
12.81%
90.81%
Biontech Se
-2.77%
44.55%
1.43%
-55.8%
195.97%
Alnylam Pharmaceuticals, Inc.
-5.94%
-2.2%
22.08%
40.33%
105.82%
Vertex Pharmaceuticals Incorporated
-12.23%
-13.26%
-0.52%
86.14%
86.27%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Humacyte Inc
1.0
NA
NA
-1.27
-8.51
-0.53
NA
-0.53
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.07
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Humacyte Inc
Buy
$680.7M
52.78%
1.0
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
90.81%
17.67
33.61%
Biontech Se
Buy
$27.3B
195.97%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.3B
105.82%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$105.8B
86.27%
32.84
-4.51%

About Humacyte

biotechnology company
Organization
Humacyte
Employees
183
CEO
Dr. Laura E. Niklason M.D., Ph.D.
Industry
Healthcare

Management People of Humacyte

NameTitle
Dr. Laura E. Niklason M.D., Ph.D.
Founder, President, CEO & Director
Mr. Dale A. Sander
CFO, Chief Corporate Development Officer & Treasurer
Dr. Heather Ledbetter Prichard Ph.D.
Chief Operating Officer
Ms. Sabrina Osborne GPHR, SPHR
Chief People Officer
Mr. William John Scheessele
Chief Commercial Officer
Dr. Shamik J. Parikh M.D.
Chief Medical Officer
Mr. Harold Alterson
Chief Quality Officer
Dr. Yang Cao M.D., Ph.D.
Chief Regulatory Officer

Important FAQs about investing in Humacyte from India :

What is Humacyte share price today?

Humacyte share price today stands at $5.50, Open: $5.38 ; Previous Close: $5.29 ; High: $5.64 ; Low: $5.14 ; 52 Week High: $9.97 ; 52 Week Low: $2.48. The stock opens at $5.38, after a previous close of $5.29. The stock reached a daily high of $5.64 and a low of $5.14, with a 52-week high of $9.97 and a 52-week low of $2.48.

Can Indians buy Humacyte shares?

Yes, Indians can invest in the Humacyte (HUMA) from India.

With INDmoney, you can buy Humacyte at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Humacyte at zero transaction cost.

How can I buy Humacyte shares from India?

It is very easy to buy Humacyte from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Humacyte be purchased?

Yes, you can buy fractional shares of Humacyte with INDmoney app.

What are the documents required to start investing in Humacyte stocks?

To start investing in Humacyte, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Humacyte

Today’s highest price of Humacyte (HUMA) is $5.64.

Today’s lowest price of Humacyte (HUMA) is $5.14.

What is today's market capitalisation of Humacyte

Today's market capitalisation of Humacyte HUMA is 680.7M

What is the 52 Week High and Low Range of Humacyte

  • 52 Week High

    $9.97

  • 52 Week Low

    $2.48

What are the historical returns of Humacyte?

  • 1 Month Returns

    23.6%

  • 3 Months Returns

    2.42%

  • 1 Year Returns

    90.31%

  • 5 Years Returns

    52.78%

Who is the Chief Executive Officer (CEO) of Humacyte

Dr. Laura E. Niklason M.D., Ph.D. is the current Chief Executive Officer (CEO) of Humacyte.